Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of α-interferon therapy

Journal of Hepatology

Volumn 22, Issue 1, 1995, Pages 22-26

  Guéchot, Jérôme ^a   Loria, Alain ^a   Serfaty, Lawrence ^a   Giral, Philippe ^a   Giboudeau, Jacqueline ^a   Poupon, Raoul ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Chronic viral hepatitis C; Hyaluronan; Hyaluronic acid; Liver fibrosis; interferon therapy

Indexed keywords

ALPHA2B INTERFERON; HYALURONIC ACID;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS HEPATITIS;

ADULT; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HEPATITIS C; HUMAN; HYALURONIC ACID; INTERFERON-ALPHA; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGE;

EID: 0028838958     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(95)80255-X     Document Type: Article

References (20)

1. Plasma clearance, tissue distribution, and metabolism of hyaluronan injected intravenously in the rabbit
2. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver
3. Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture
4. Polydispersity of acidic glycosamino glycan components in human liver and the changes at different stages in liver cirrhosis
5. Increased serum levels of hyaluronidate in liver disease
6. Serum hyaluronidate in primary biliary cirrhosis: a biochemical marker for progressive liver damage
7. Serum hyaluronidate in liver diseases: study by enzymoimmunological assay
8. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease
9. Biochemical markers of hepatic fibrosis in primary biliary cirrhosis
10. Relationship between procollagen III aminoterminal propeptede and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C
11. Biochemical markers of hepatic fibrosis [Review]
12. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial
13. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind placebo controlled trial
14. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis
15. Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis
16. A hyaluronan-loading test applied to patients with liver and joint diseases
17. Endothelial cells are the site of uptake and degradation of hyaluronic acid in the liver
18. Gram-negative bacterial lipopolysaccharide impairs hyaluronan clearance in vivo and its uptake by the isolated, perfused rat liver
19. Cellular sources of non collagenous matrix proteins: role of fat-storing cells in fibrogenesis
20. Transforming growth factor β1 and α in chronic liver disease. Effect of interferon alfa therapy